• Accueil
• tpex
• ASLAN moves primary listing from TPEx to Nasdaq

ASLAN moves primary listing from TPEx to Nasdaq

4.6 (320) · € 29.99 · En Stock

Life Pre- and Post-IPO: The journey of iX Biopharma and ASLAN

asln-20f_20201231.htm

SEC Filing Belite Bio, Inc.

SEC Filing ASLAN Pharmaceuticals

424B5

F-1

SEC Filing ASLAN Pharmaceuticals

asln-20f_20201231.htm

Inline XBRL Viewer

SJS 2022 Dimensions - Flipbook by Edspire

Piedmont Lithium Announces First Commercial Shipments From North

SEC Filing Belite Bio, Inc.

SEC Filing ASLAN Pharmaceuticals

asln-20f_20181231.htm